$ 966.72
Details
An independent, easy-to-use, fully-characterized, multi-analyte positive control for multiplex or standard NAT donor screening or patient monitoringFormulated for use with in vitro diagnostic test methods that detect HIV-1 RNA, HCV RNA and HBV DNAACCURUN 345 Series 150 is prepared by diluting separate stocks of known titers of HIV-1 RNA, HCV RNA and HBV DNA with defibrinated plasmaFormulated to low concentration levels of HIV-1 RNA, HCV RNA and HBV DNA; challenge assay performance near limit of detectionSpecifically formulated for manual and automated assay platforms to help monitor both assay and instrument integrityHuman plasma based controls mimic patient samples Monitor all aspects of sample testing, from sample lysis and extraction through PCR amplifiction and detectionIndependent controls meet compliance requirements of regulatory agencies and professional organizationsLiquid, ready-to-use - no reconstitution or special handling required Extended shelf life means efficiency for labs, allowing assay performance to be monitored with same lot over an extended period of timeAll SeraCare facilities are ISO 9001 and 13485 certified and comply with cGMP standardsRoutine use of independent controls helps monitor day-to-day test variability, lot-to-lot variability and staff performance
